Structural Basis for Selective Inhibition of Trypanosomatid Glyceraldehyde-3-Phosphate Dehydrogenase: Molecular Docking and 3D QSAR Studies

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Chemical Information and Modeling

• Publication date

  2008-02-28

• Fields of study

  Biology, Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1021/ci700453jPMID 18303835
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Virtual screening and its integration with modern drug design technologies.

  2008cited by this paper
• Bisphosphonates as Inhibitors of Trypanosoma cruzi Hexokinase

  2007cited by this paper
• 3D QSAR comparative molecular field analysis on nonsteroidal farnesoid X receptor activators.

  2007cited by this paper
• 2D Quantitative structure-activity relationship studies on a series of cholesteryl ester transfer protein inhibitors.

  2007cited by this paper
• Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.

  2007cited by this paper
• Human monogenic disorders — a source of novel drug targets

  2006cited by this paper
• A critical assessment of docking programs and scoring functions.

  2006cited by this paper
• High-resolution structure of human D-glyceraldehyde-3-phosphate dehydrogenase.

  2006cited by this paper
• Structure-based 3D-QSAR studies on thiazoles as 5-HT3 receptor antagonists

  2006cited by this paper
• Drive for drugs leads to baby clinical trials.

  2006cited by this paper
• Proteases in parasitic diseases.

  2006cited by this paper
• Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors.

  2006cited by this paper
• Highly Predictive CoMFA and CoMSIA Models for Two Series of Stromelysin-1 (MMP-3) Inhibitors Elucidate S1' and S1-S2' Binding Modes

  2006cited by this paper
• Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase.

  2005cited by this paper
• Structure-activity relationships for the design of small-molecule inhibitors.

  2005cited by this paper
• Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators.

  2005cited by this paper
• 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.

  2004cited by this paper
• 3D-QSAR illusions

  2004cited by this paper
• Improved protein–ligand docking using GOLD

  2003cited by this paper
• A guide to drug discovery: Trends in development and approval times for new therapeutics in the United States

  2003cited by this paper
• Comparative evaluation of 11 scoring functions for molecular docking.

  2003cited by this paper
• Rational selection of training and test sets for the development of validated QSAR models

  2003cited by this paper
• Drugs for the control of parasitic diseases: current status and development.

  2003cited by this paper
• Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs.

  2003cited by this paper
• Beware of q2!

  2002cited by this paper
• Control of Chagas disease.

  2002cited by this paper
• Glycolysis as a target for the design of new anti-trypanosome drugs.

  2001cited by this paper
• Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.

  2001cited by this paper
• Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors.

  2001cited by this paper
• Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations.

  2000cited by this paper
• Compartmentation protects trypanosomes from the dangerous design of glycolysis.

  2000cited by this paper
• Metabolic aspects of glycosomes in trypanosomatidae - new data and views.

  2000cited by this paper
• Comparative Molecular Similarity Index Analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries

  1999cited by this paper
• What Controls Glycolysis in Bloodstream Form Trypanosoma brucei?*

  1999cited by this paper
• Structure-activity relationships for a class of inhibitors of purine nucleoside phosphorylase.

  1999cited by this paper
• Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase.

  1999cited by this paper
• Trypanosoma cruzi glycosomal glyceraldehyde‐3‐phosphate dehydrogenase: structure, catalytic mechanism and targeted inhibitor design

  1998cited by this paper
• Drug target validation and identification of secondary drug target effects using DNA microarrays

  1998cited by this paper
• Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.

  1998cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper
• A fast flexible docking method using an incremental construction algorithm.

  1996cited by this paper
• Crystal structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Leishmania mexicana: implications for structure-based drug design and a new position for the inorganic phosphate binding site.

  1995cited by this paper
• Synthesis and structure-activity relationships of analogs of 2'-deoxy-2'-(3-methoxybenzamido)adenosine, a selective inhibitor of trypanosomal glycosomal glyceraldehyde-3-phosphate dehydrogenase.

  1995cited by this paper
• Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

  1994cited by this paper
• Selective inhibition of trypanosomal glyceraldehyde-3-phosphate dehydrogenase by protein structure-based design: toward new drugs for the treatment of sleeping sickness.

  1994cited by this paper
• Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA

  1993cited by this paper
• Structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei determined from Laue data.

  1993cited by this paper
• Recent advances in comparative molecular field analysis (CoMFA).

  1989cited by this paper
• Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

  1988cited by this paper

• TcGAPDH peptidic inhibitors derived from dinoponeratoxin M-PONTX-Dq4e with trypanocidal effect.

  2025cites this paper
• Metallodrugs for the treatment of Trypanosomatid diseases: recent advances and new insights.

  2020cites this paper
• Design of Inhibitors for Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) Enzyme of Leishmania mexicana.

  2020cites this paper
• New Molecular Targets and Strategies for Antimalarial Discovery.

  2017cites this paper
• Molecular basis for covalent inhibition of glyceraldehyde‐3‐phosphate dehydrogenase by a 2‐phenoxy‐1,4‐naphthoquinone small molecule

  2017cites this paper
• 2D and 3D QSAR Studies on a Series of Antichagasic Fenarimol Derivatives

  2017cites this paper
• In silico investigation of medicinal spectrum of imidazo-azines from the perspective of multitarget screening against malaria, tuberculosis and Chagas disease.

  2014cites this paper
• Glycosomal targets for anti-trypanosomatid drug discovery.

  2014cites this paper
• Pattern Recognition Techniques Applied to the Study of Leishmanial Glyceraldehyde-3-Phosphate Dehydrogenase Inhibition

  2014cites this paper
• CoMFA and CoMSIA studies on a series of fluroquinolone derivatives for potential anti-inflammatory activity

  2014cites this paper
• CoMFA and CoMSIA 3D QSAR models for a series of some condensed thieno[2,3-d]pyrimidin-4(3H)-ones with antihistaminic (H1) activity.

  2013cites this paper
• Drug Design and Screening by In Silico Approaches

  2013cites this paper
• A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors.

  2013cites this paper
• In-silico Leishmania Target Selectivity of Antiparasitic Terpenoids

  2013cites this paper
• Identification of Electronic and Structural Descriptors of Adenosine Analogues Related to Inhibition of Leishmanial Glyceraldehyde-3-Phosphate Dehydrogenase

  2013cites this paper
• Interactions of antiparasitic alkaloids with Leishmania protein targets: a molecular docking analysis.

  2013cites this paper
• 3',5'-Dibromo-2',4'-dihydroxy Substituted Chalcones: Synthesis and in vitro Trypanocidal Evaluation

  2012cites this paper
• Synthesis and Trypanocidal Evaluation of Some Novel 2-(Substituted Benzylidene)-5, 7-Dibromo-6-Hydroxy-1-Benzofuran-3(2H)-Ones

  2012cites this paper
• Two personal perspectives on a key issue in contemporary 3D QSAR

  2012cites this paper
• Quantitative structure-activity studies on a series of migrastatin analogs as inhibitors of cancer cell metastasis.

  2011cites this paper
• Drug discovery and the use of computational approaches for infectious diseases.

  2011cites this paper
• In silico screening strategies for novel inhibitors of parasitic diseases

  2011cites this paper
• Comparative molecular field analysis of a series of inhibitors of HIV-1 protease.

  2011cites this paper
• Planejamento de fármacos, biotecnologia e química medicinal: aplicações em doenças infecciosas

  2010cites this paper
• Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands.

  2010cites this paper
• Discovery of New Inhibitors of Schistosoma mansoni PNP by Pharmacophore-Based Virtual Screening

  2010cites this paper
• Genetic validation of aldolase and glyceraldehyde-3-phosphate dehydrogenase as drug targets in Trypanosoma brucei.

  2010cites this paper
• New drugs for neglected infectious diseases: Chagas' disease

  2010cites this paper
• Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity

  2010influential citation
• Tailoring NO donors metallopharmaceuticals: ruthenium nitrosyl ammines and aliphatic tetraazamacrocycles.

  2010cites this paper
• Structural basis for selective inhibition of purine nucleoside phosphorylase from Schistosoma mansoni: kinetic and structural studies.

  2010cites this paper
• Recent Trends in Structure‐Based Drug Design and Energetics

  2010cites this paper
• Fragment-based QSAR: perspectives in drug design

  2009cites this paper
• Fragment-Based QSAR and Molecular Modeling Studies on a Series of Discodermolide Analogs as Microtubule-Stabilizing Anticancer Agents

  2009cites this paper
• CoMFA and CoMSIA 3D QSAR Models for a Series of Cyclic Imides with Analgesic Activity

  2009cites this paper
• Structure-based drug discovery for tropical diseases.

  2009cites this paper
• CoMFA and CoMSIA 3D QSAR models for a series of cyclic imides with analgesic activity.

  2009cites this paper
• Role of Halogen Bonds in Thyroid Hormone Receptor Selectivity: Pharmacophore-Based 3D-QSSR Studies

  2009cites this paper
• Structure-based drug design strategies in medicinal chemistry.

  2009cites this paper
• Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.

  2009cites this paper
• UNIVERSIDADE DE SÃO PAULO INSTITUTO DE FÍSICA DE SÃO CARLOS

  2008cites this paper
• Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines.

  2008cites this paper
• Structure-Based Approach for the Study of Estrogen Receptor Binding Affinity and Subtype Selectivity

  2008cites this paper
• Fragment-based and classical quantitative structure–activity relationships for a series of hydrazides as antituberculosis agents

  2008cites this paper